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Background: This is the ﬁrst genetic biodiversity study of
M. tuberculosis in Iran. Thus, we investigated the genetic
patterns of strains isolated in the ﬁrst survey of anti-
tuberculosis drug-resistance by rpoB gene as part of the
Global Project of Anti-tuberculosis Drug Resistance Surveil-
lance (IPI, Iran).
Material and Method: A 411-bp fragment of the rpoB
gene, containing the sequence of the 81-bp rpoB fragment,
was ampliﬁed by PCR and the rpoB gene fragments of tuber-
culosis strains were sequenced using the Amersham auto
sequencer. For analysing tree evolution used method UPGMA
and Neighbour-Joining. Clinical isolates (34/163) were ana-
lyzed by using sequencing gene rpoB and genotyped by
program MEGA.
Results: The results were compared with the interna-
tional database. MDR was 14% in never treated patients and
8% in previously treated patients. Mutations in rpoB gene
and katG genes were detected in 95% and 84% of the MDR
strains, respectively. Two clusters were found to be identical
by the four different analysis methods, presumably repre-
senting cases of recent transmission of MDR tuberculosis.
The other strains are divided into 2 groups: group A - simi-
lar to the standard and Eastern strains (China, Taiwan) and
group B - strains of another genotype. They are grouped
separately on the dendrogram and became prevalent in Iran
(they are called Iranian residential strains).
Conclusion: This study gives a ﬁrst overview of the M.
tuberculosis strains circulating in Iran during the ﬁrst survey
of anti-tuberculosis drug-resistance. It may aid in the cre-
ation of a national database that will be a valuable support
for further studies.
doi:10.1016/j.ijid.2008.05.897
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Tuberculosis (TB) is increasing at alarming rates in Papua
New Guinea (PNG). WHO revealed a staggering incidence
rate of 104/100 000 population in 2004, which coincided
with a mere 20% case-detection rate. TB drug resistance
has never been investigated, however is anticipated to be
present in high proportions. This hospital-based perspec-
tive study was aimed at investigating the distribution of
pulmonary TB and TB drug resistance, with speciﬁc objec-
tives of establishing drug resistance proﬁle for this study
setting and providing a form of guideline for future drug
resistance monitoring and therapy approaches in hospi-
tal settings in PNG. Patients were recruited on routine
presentation at Modilon Hospital, Madang Province. Direct
smear microscopy was carried out followed by sputum pro-
cessing using 4% sodium hydroxide (NaOH). Culture and
drug resistance testing were performed using the BACTEC
MGIT960 Culture System. A total of 339 new TB patients
were recruited between January and December of 2006 and
53% were positive for acid-fast bacilli. Two hundred and
forty samples were cultured and 30.4% (73/240) showed
positive growth. Drug resistance testing was successfully
carried out in 69 isolates, of which 92.8% were from new
TB cases. Overall drug resistance was therefore, observed
in 17.4% (11 new cases and 1 previously treated case).
Multiple drug resistant TB (MDR-TB) was detected in 8.7%
(5 new TB cases and 1 previously treated case). Resis-
tance to at least streptomycin was the most common (75%
of all drug resistant cases) followed by resistance to at
least rifampicin (50%). This study provided the ﬁrst evi-
dence of TB drug resistance in PNG. MDR-TB alone was the
most common form of TB drug resistance observed in this
study. Madang province is rated as median risk for TB, thus
further investigation is required in high risk areas of TB
in PNG.
doi:10.1016/j.ijid.2008.05.898
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The 60 Years Battle Against Tuberculosis in Hong Kong - A
Review of the Past and a Projection Into the 21st Century
S.H. Lee
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tion, Hong Kong, China
Background: In October 2008, the Hong Kong Tuberculo-
sis, Chest and Heart Diseases Association will be celebrating
